Research / CBT / Fundamental state Inspectable configuration
State dimensions Filing 0000950170-24-012680 General Corporate
Debt relative to revenue 65th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
136.95% · OPTIONAL · VALID
Capex intensity 50th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
5.64% · OPTIONAL · VALID
Operating cash generation 65th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
10.96% · OPTIONAL · VALID
Revenue growth 40th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-0.73% · CORE · VALID
Inventory pressure 70th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
64.41% · OPTIONAL · VALID
Gross margin 75th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
22.76% · CORE · VALID
Operating margin 70th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
14.20% · CORE · VALID
R&D intensity 45th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.57% · OPTIONAL · VALID
SBC intensity 90th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.63% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 36 states Self-history eligible
Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Dec 31, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 9/9 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 27.52%
Current 136.95%
Delta 109.43% Capex Intensity Decreased
Previous 6.21%
Current 5.64%
Delta -0.57% Cash Generation Decreased
Previous 15.14%
Current 10.96%
Delta -4.18% Growth Increased
Previous -9.03%
Current -0.73%
Delta 8.30% Inventory Pressure Increased
Previous 14.88%
Current 64.41%
Delta 49.52% Margin Increased
Previous 21.34%
Current 22.76%
Delta 1.41% Profitability Increased
Previous 13.38%
Current 14.20%
Delta 0.82% R And D Intensity Increased
Previous 1.45%
Current 1.57%
Delta 0.12% Sbc Intensity Increased
Previous 0.51%
Current 0.63%
Delta 0.12% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.